AstraZeneca (NYSE: AZN) and Peregrine Pharma (NASDAQ: PPHM) announced that they have entered into a cancer immunotherapy clinical trial collaboration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE